Androgen receptor agonism promotes an osteogenic gene program in preadipocytes

Biochemical and Biophysical Research Communications

Volumn 434, Issue 2, 2013, Pages 357-362

  Hartig, Sean M ^a   Feng, Qin ^a   Ochsner, Scott A ^a   Xiao, Rui ^a   McKenna, Neil J ^a   McGuire, Sean E ^a   He, Bin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adipocyte; Androgen receptor; Gene regulation; Osteoblast

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BONE DEVELOPMENT; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DNA MICROARRAY; EPIDIDYMIS FAT; GENE EXPRESSION REGULATION; LIPID STORAGE; MARKER GENE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROADIPOCYTE; RECEPTOR UPREGULATION; RETROPERITONEAL FAT; SUBCUTANEOUS FAT;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANDROGENS; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; GENE EXPRESSION REGULATION; HUMANS; LENTIVIRUS; METRIBOLONE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOGENESIS; RECEPTORS, ANDROGEN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TESTOSTERONE CONGENERS; TRANSCRIPTOME; TRANSGENES;

EID: 84877054596     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.078     Document Type: Article

References (45)

1. Callewaert F., Boonen S., Vanderschueren D. Sex steroids and the male skeleton: a tale of two hormones. Trends Endocrinol. Metab. 2010, 21:89-95.
2. Reid I.R., Ames R., Evans M.C., et al. Determinants of total body and regional bone mineral density in normal postmenopausal women-a key role for fat mass. J. Clin. Endocrinol. Metab. 1992, 75:45-51.
3. Reid I.R., Plank L.D., Evans M.C. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J. Clin. Endocrinol. Metab. 1992, 75:779-782.
4. Albala C., Yanez M., Devoto E., et al. Obesity as a protective factor postmenopausal osteoporosis. Int. J. Obes. Relat. Metab. Disord. 1996, 20:1027-1032.
5. Khosla S., Atkinson E.J., Riggs B.L., et al. Relationship between body composition and bone mass in women. J. Bone Miner. Res. 1996, 11:857-863.
6. Janicka A., Wren T.A., Sanchez M.M., et al. Fat mass is not beneficial to bone in adolescents and young adults. J. Clin. Endocrinol. Metab. 2007, 92:143-147.
7. Gilsanz V., Chalfant J., Mo A.O., et al. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J. Clin. Endocrinol. Metab. 2009, 94:3387-3393.
8. Russell M., Mendes N., Miller K.K., et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J. Clin. Endocrinol. Metab 2010, 95:1247-1255.
9. Bredella M.A., Torriani M., Ghomi R.H., et al. Determinants of bone mineral density in obese premenopausal women. Bone 2011, 48:748-754.
10. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of human mesenchymal stem cells. Science 1999, 284:143-147.
11. Schiller P.C., D'Ippolito G., Brambilla R., et al. Inhibition of gap-junctional communication induces the trans-differentiation of osteoblasts to an adipocytic phenotype in vitro. J. Biol. Chem. 2001, 276:14133-14138.
12. Wolf N.S., Penn P.E., Rao D., et al. Intraclonal plasticity for bone, smooth muscle, and adipocyte lineage in bone marrow stroma fibroblastoid cells. Exp. Cell Res. 2003, 290:346-357.
13. Hartig S.M., He B., Newberg J.Y., et al. Feed-forward inhibition of androgen receptor activity by gluococorticoid action in human adipocytes. Chem. Biol. 2012, 19:1126-1141.
14. Fu M., Sun T., Bookout A.L., et al. A nuclear receptor atlas: 3T3-L1 adipogenesis. Mol. Endocinol. 2005, 19:2437-2450.
15. Lahnalampi M., Heinaniemi M., Sinkkonen L., et al. Time-resolved expression profiling of the nuclear receptor superfamily in human adipogenesis. PLOS One 2010, 5:e12991.
16. Singh R., Artaza J.N., Taylor W.E. M., et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006, 147:141-154.
17. Christy R.J., Kaestner K.H., Geiman D.E., et al. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA 1991, 88:2593-2597.
18. Tang Q.Q., Lane M.D. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev. 1999, 13:2231-2241.
19. Steger D.J., Grant G.R., Schupp M., et al. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 2010, 24:1035-1044.
20. Siersbaek R., Nielsen R., John S., et al. Extensive chromatin remodeling and establisment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 2011, 30:1459-1472.
21. Smas C.M., Hui H.S. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993, 73:725-734.
22. Smas C.M., Kachinskas D., Liu C.M., et al. Transcriptional control of the pref-1 gene in 3T3-L1 adipocyte differentiation. Sequence requirement for differentiation-dependent suppression. J. Biol. Chem. 1998, 273:31751-31758.
23. Pantoja C., Huff J.T., Yamamoto K.R. Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro. Mol. Biol. Cell 2008, 19:4032-4041.
24. Wu Z.D., Rosen E.D., Brun R., et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 1999, 3:151-158.
25. Rosen E.D., Hsu C.H., Wang X.Z., et al. C/EBP alpha induces adipogenesis through PPAR gamma: a unified pathway. Genes Dev. 2002, 16:22-26.
26. Tang Q.Q., Otto T.C., Lane M.D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:44-49.
27. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat. Rev. Endocrinol. 2009, 5(2009):673-681.
28. Wang C., Nieschlag E., Swerdloff R., Behre H.M., Hellstrom W.J., Gooren L.J., Kaufman J.M., Legros J.J., Lunenfeld B., Morales A., Morley J.E., Schulman C., Thompson I.M., Weidner W., Investigation F.C.W. Wu. Treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J. Androl. 2009, 30:1-9.
29. Behre H.M., Kliesch S., Leifke E., et al. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J. Clin. Endocrinol. Metab. 1997, 82:2386-2390.
30. Kapoor D., Goodwin E., Channer K.S., et al. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol. 2006, 154:899-906.
31. Snyder P.J., Peachey H., Berlin J.A., et al. Effects of testosterone replacement in hypogonadal men. Effects of testosterone replacement in hypogonadal men 2000, 85:2670-2677.
32. McInnes K.J., Smith L.B., Hunger N.I., et al. Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis. Diabetes 2012, 61:1072-1081.
33. Schupp M., Cristancho A.G., Lefterova M.I., et al. Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-gamma depletion to revert the adipocyte phenotype. J. Biol. Chem. 2009, 284:9458-9464.
34. Rosen E.D., Sarraf P., Troy A.E., et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 1999, 4:611-617.
35. Paic F., Igwe J.C., Nori R., et al. Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 2009, 45:682-692.
36. Kim H.J., Minashima T., McCarthy E.F., et al. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling. J. Bone Miner. Res. 2010, 25:1771-1783.
37. Petryk A., Shimmi O., Jia X., et al. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells. Bone 2005, 36:617-626.
38. Macsai C.E., Georgiou K.R., Foster B.K., et al. Microarray expression analysis of genes and pathways involved in growth plate cartilage injury responses and bony repair. Bone 2012, 50:1081-1091.
39. Parisi M.S., Gazzerro E., Rydziel S., et al. Expression and regulation of CCN genes in murine osteoblasts. Bone 2006, 38:671-677.
40. Wi S., Kang Q., Luu H.H., et al. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol. Cell. Biol. 2006, 26:2955-2964.
41. Hessle L., Johnson K.A., Anderson H.C., et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl. Acad. Sci. USA 2002, 99:9445-9449.
42. Nam H.K., Liu J., Kragor A., et al. Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation. J. Biol. Chem. 2011, 286:39059-39071.
43. Tezuka K., Yasuda M., Watanabe N., et al. Simulation of osteoblastic cell differentiation by Notch. J. Bone Miner. Res. 2002, 17:231-239.
44. Engin F., Yao Z., Yang T., et al. Dimorphic effects of Notch signaling in bone homeostasis. Nat. Med. 2008, 14:299-305.
45. Reinholt F.P., Hultenby K., Oldberg A., et al. Osteopontin-a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA 1990, 87:4473-4475.